Massachusetts Financial Services’s Akebia Therapeutics AKBA Stock Holding History

Massachusetts Financial Services’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-226,786	Closed	-$569K	–	879
2020 Q3	$569K	Sell	226,786 -8,886	-4%	-$78K	﹤0.01%	822
2020 Q2	$3.2M	Sell	235,672 -120,082	-34%	-$1.24M	﹤0.01%	652
2020 Q1	$2.7M	Buy	355,754 +47,752	+16%	+$372K	﹤0.01%	655
2019 Q4	$1.95M	Sell	308,002 -33,248	-10%	-$158K	﹤0.01%	712
2019 Q3	$1.34M	Buy	341,250 +38,078	+13%	+$163K	﹤0.01%	757
2019 Q2	$1.47M	Buy	303,172 +64,336	+27%	+$366K	﹤0.01%	766
2019 Q1	$1.96M	Buy	+238,836	New	+$1.64M	﹤0.01%	720
2018 Q3	–	Sell	-133,598	Closed	-$1.33M	–	853
2018 Q2	$1.33M	Buy	+133,598	New	+$1.34M	﹤0.01%	751

Other funds holding AKBA

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Massachusetts Financial Services's AKBA Position: Q4 2020 in Review

Massachusetts Financial Services sold out of Akebia Therapeutics (AKBA) in Q4 2020, closing a stake of 226,786 shares — an estimated $569K sold.

Massachusetts Financial Services first reported a position in AKBA in Q2 2018 and held it in 8 quarters. The position peaked at $3.2M in Q2 2020. 143 funds tracked by Wall St. Rank hold AKBA as of Q4 2020.

Massachusetts Financial Services reported no remaining Akebia Therapeutics position as of Q4 2020 after selling out during the quarter.
Massachusetts Financial Services sold 226,786 Akebia Therapeutics shares in Q4 2020, an estimated $569K.
Massachusetts Financial Services first reported a position in Akebia Therapeutics in Q2 2018 and held it in 8 quarters.
Massachusetts Financial Services's Akebia Therapeutics position peaked at $3.2M in Q2 2020.
143 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q4 2020.

Based on Massachusetts Financial Services's 13F filing for Q4 2020, filed 12 Feb 2021.